Revlon and Dr. Patricia Wexler Join Forces for the Development of Skin Care and Cosmetic Products

Search Blogs that Mention this News Release

Click this link to view linked Bookmarking Services

Click this link to view linked Blogging Services

Revlon and Dr. Patricia Wexler Join Forces for the Development of Skin Care and Cosmetic Products

    NEW YORK, June 28 /PRNewswire/ -- Revlon, Inc. (NYSE: REV) today announced
that it has signed an agreement with Dr. Patricia Wexler under which she would
provide consulting services related to the development and promotion of new
skin care and cosmetic products for the mass market.
    Jeffrey M. Nugent, President and CEO, said "Dr. Wexler's medical expertise
and her experience with skin care product development make her an ideal
partner for Revlon."  He added, "We have committed to making significant
strides in this product category and, as we enter 2001, Pat will help us
dramatically accelerate our pace."
    Patricia Wexler, M.D., specializes in dermatology and dermatologic
surgery, including state-of-the-art cosmetic surgical procedures.  Currently
an attending physician at Beth Israel Medical Center, Dr. Wexler teaches at
its dermatology surgery clinic and operates a successful private practice in
Manhattan.  She is an assistant clinical professor at Albert Einstein School
of Medicine, and is a board certified member of both the American Board of
Internal Medicine and the American Board of Dermatology, as well as Fellow of
the American Society of Dermatologic Surgery.  She was the recipient of the
American Academy of Cosmetic Surgery Award for Excellence in Cosmetic Surgery.
She is a published author of medical research and has been a consultant in the
development of several skin care and make-up lines currently available in
specialty stores nationwide.
    Dr. Wexler said, "Interest in maintaining and even improving the
appearance of our skin has never been stronger, and the opportunities for
Revlon in this area are very promising.  I am very excited to be part of this
collaboration."
    In a related announcement, Revlon announced on June 15, 2000, that they
had entered into an exclusive licensing agreement with Senetek PLC, a
biopharmaceutical company, which provides Revlon with Senetek's patented
Kinetin(TM) skincare technology for use in creating skin care and cosmetic
products.  Terms of the agreement grant Revlon exclusive worldwide rights for
Kinetin(TM) in the mass market, excluding parts of Asia.
    Revlon is a worldwide cosmetics, skin care, fragrance, and personal care
products company.  The Company's vision is to become the world's most dynamic
leader in global beauty and skin care.  A web site featuring current product
and promotional information can be reached at http://www.revlon.com.  Revlon
brands include Revlon(R), Almay(R), Ultima II(R), Charlie(R) and Flex(R), and
they are sold in approximately 175 countries and territories.

SOURCE Revlon, Inc.

http://www.revlon.com
CONTACT:
Media - Richard Woods, 212-527-5791, or
Investors - Laura Kiernan, 212-527-5230, both of Revlon